During the last ESHRE in Geneva Lo.Li. Pharma International was present with a booth and yet again we experienced a great interest in our portfolio from all visitors.
During the ESHRE, Prof. John Nestler from USA, being one of the most relevant names in the PCOS field, gave a speech regarding the role of Inositols in PCOS. He concluded the speech stating that:

  • A 40:1 ratio of Myo-inositol and D-chiro-inositol can be used to synergistically improve ovarian function and metabolic/endocrine processes;
  • This combination may be especially useful to treat overweight/obese women with PCOS.